Woodstock, GA – July 27, 2015 A meeting entitled Workflow Considerations With Use of ENFit™ Feeding tubes and Associated Devices was held on July 16 and included industry, clinicians, regulators and patient advocacy groups. One of the headlining topics discussed was precise dosing measurements using an ENFit tipped enteral syringe for medication administration of <2 mL.
Woodstock, GA – May 21, 2015 – NeoMed, Inc. is proud to name Marc Waldman as its new Vice President of Sales. Mr. Waldman has been with NeoMed for just over a year serving as the Director of Business Development and has demonstrated great success leading our national sales force.
Mr. Waldman has an accomplished history of sales, marketing and general management success within the medical device industry. Most recently, he was Co-Owner and Principal of West Branch Medical, LLC where he managed sales and operations of a maternal-child health products focused Sales, Marketing and Distribution company. His years of progressive experience have included positions involving sales and marketing management as well as recruiting and training.
“Marc’s strengths in strategic planning and effective execution have been both evident and demonstrated during his time with us and we look forward to his expanded role” commented NeoMed President Aaron Ingram. “He brings a wealth of sales leadership experience and is uniquely positioned to help us achieve the growth opportunity ahead of us.”
Mr. Waldman attended the College of New Jersey and lives with his wife and four kids in Yardley, PA.
Woodstock, GA – May 29, 2015 NeoMed, Inc., a market leader and innovator of neonatal nutrition/enteral safety devices, announced that it received FDA 510(K) clearance from the United States Food and Drug Administration (FDA) for its NeoConnect Enteral Syringes with ENFit connector (K143344) on April 8, 2015. NeoMed is currently one of only two enteral syringe manufacturers that have received FDA 510(K) clearance for enteral syringes with ENFit connectors.
The NeoConnect syringes are an important part of the NeoMed solutions for the ISO 80369-3 (ENFit) Small Bore Connector Standard, being implemented to help reduce the risk of tubing misconnections and improve patient safety. NeoMed designed the first comprehensive enteral safety system to comply with the recommendations of the Joint Commission, FDA, ASPEN, and AAMI to help prevent tubing misconnections and is proud to support the ENFit initiative.
Aaron Ingram, President of NeoMed, Inc. says “Our commitment to our customers is our continual participation with GEDSA, the trade association created to help introduce the new standards. We will continue our support of the new ISO 80369-3 standard through implementation, practice, and beyond.”
“NeoConnect represents a portfolio of intellectual property and embodies the unwavering commitment of NeoMed to pursue innovative solutions that help the most vulnerable patient – the neonate,” commented NeoMed CEO Tony Lair. “We are excited to be able to provide our customers with a full line of NICU and pharmacy products to help them navigate the implementation of ENFit enteral access devices.”
NeoConnect products will be available to customers in alignment with the GEDSA timeline for introduction of ENFit (www.stayconnected.org).
Woodstock, GA – April 22, 2015 – Click here to watch the Stay Connected Initiative Overview video – Reducing the risk of medical device tubing misconnections. Learn about the issue and prepare to transition to the new ENFit connector for enteral feeding from GEDSA. For more information visit www.stayconnected.org.
Woodstock, GA – April 14, 2015 – The February 2015 issue of Healthcare Purchasing News included an interview with Marc Waldman (NeoMed Director of Business Development) describing enteral device technology and the impact on nutrition delivery. The article’s focus is on reduced readmissions and improved clinical outcomes through correct diagnosis and proper nutrition. Contributing to that is the significant impact syringe design has on critical lipid delivery to the Neonatal Patient. Marc states in the article that “A significant focus for NeoMed has been to demonstrate that our enteral devices work to preserve the macro/micro nutrients vital for the development of the micro-preemie to term patient. Morbidity is significantly reduced by patients that reach a return to birth weight within 14 days.” For additional details and to read the full article visit http://www.hpnonline.com/inside/2015-02/1502-OR-Nutrition.html
Woodstock, GA – April 9, 2015 –The Institute for Safe Medication Practices (ISMP) published The Medication Safety Alert entitled ENFit Enteral Devices are on the Way: Important Safety Considerations for Hospitals. The alert provides a detailed analysis of potential process and protocol changes facing pharmacies and patient care units, including the NICU.
NeoMed was proud to provide the samples of the new ENFit devices for simulation in the article. NeoMed stands ready to demonstrate our Pharmacy to NICU ENFit solutions.
Woodstock, GA – March 6, 2015 – NeoMed is one of 44 award recipients of this year’s GLOBE, an acronym for ‘Georgia Launching Opportunities by Exporting.’ Award recipients span 17 counties and have business dealings in 104 unique countries and territories. Learn More
Woodstock, GA – March 24, 2014 – The Institute for Safe Medication Practice (ISMP) published their 2014-15 Targeted Medication Safety Best Practices for Hospitals in January 2014. ISMP states the goal of Best Practice #5 is to “use liquid medication dosing devices that only display volume using the metric scale (mL)”. ISMP cites the potential for medication measurement mix-ups and hopes to reduce that risk by issuing their Targeted Medication Safety Best Practices.
In response to this best practice recommendation, NeoMed has removed all teaspoon gradient markings from their Pharmacy Oral Dispenser line. NeoMed plans to have the new Pharmacy Oral Dispensers with milliliter-only markings ready for delivery in May for small volumes (less than 12 mL) and June for large volumes (20 mL – 60 mL).
Please click here to contact your local distributor to place an order or for more information.
Woodstock, GA – May, 2014 – NeoMed recently published a white paper investigating the impact of syringe design on lipid loss in human breast milk. Click to find out how off-center tip and plunger/piston design can help reduce lipid loss, and thus NEC and BPD.
Dublin, 21st February, 2014 – NeoMed, Inc., a leading manufacturer of enteral nutrition delivery devices for neonatal and paediatric patients, today announced plans to establish an International Headquarters in Dublin, with the creation of 22 jobs. Their new International HQ will be responsible for all sales outside of the US.
NeoMed’s immediate focus is on building an Irish team of Sales and Marketing representatives, supported by Administrative and Customer Service professionals over the next 3 years to drive growth outside of the US. NeoMed has further plans to expand its footprint to include Research & Development activities at a later date. Recruitment for the new roles will begin later in 2014.
Tony Lair CEO & President of NeoMed, Inc. said “Ireland was the right fit for us to expand our product line into the European marketplace, which is another key milestone for NeoMed to become the leading producer of enteral safety devices worldwide.”
Woodstock, GA – November, 2013 – To help promote awareness of the new ISO Small Bore Connector Standard in 2014, NeoMed has joined GEDSA, the Global Enteral Device Supplier Association, as an Associate Member. The new ISO 80369-3 Small Bore Connector Standard will help reduce the risk of tubing misconnections and improve patient safety. NeoMed designed the first comprehensive enteral safety system to comply with the recommendations of the Joint Commission, FDA, ASPEN, and AAMI to help prevent tubing misconnections. NeoMed continues to design products that help improve patient safety and supports GEDSA’s effort to raise awareness about the new connector standard. For more information about the implementation of the new standard, please visit GEDSA.
Woodstock, GA – April 30, 2013 – NeoMed is proud to announce the publication of their United States Patent US 8,430,865 Enteral Safety System and Methods. NeoMed’s color matching ESS technology is fundamental in providing patient protection from common misconnection errors in the NICU/PICU. As cited by the Joint Commission, FDA, ASPEN, and the ADA, color coordination within components of an enteral system creates a visual reminder that color-matched devices function as enteral, and not vascular, systems. Furthermore, the patented NeoMed system maintains color matching in a number of different clinical settings in both gravity feeds and syringe pump applications.
Kennesaw, GA – February 21, 2013 – NeoMed, Inc., a leading manufacturer of enteral nutrition delivery devices, held their annual National Sales Meeting on February 20 and 21. More than forty sales representatives attended, representing twelve independent dealers and two NeoMed direct sales reps from the United States and Puerto Rico. The purpose of the annual sales meeting is to bring the salesforce together for training on new products, breakout session discussion, and the recognition of outstanding dealers with the announcement of dealer’s awards.
Tony Lair, President of NeoMed, presented the 2012 NeoMed Dealer of the Year award to Marc Waldman, principal of West Branch Medical. West Branch Medical experienced a significant 45% growth between 2011 and 2012, with upwards of $900,000 in sales. West Branch Medical is committed to enhancing their product knowledge, training four of their sales representatives at NeoMed’s New Rep Training on February 19. Headquartered outside of Philadelphia, PA, West Branch Medical, LLC is a locally owned and operated provider of medical devices and services, with a reputation of providing top quality products, cutting-edge technology, and an unparalleled commitment to customer service.
Tony Lair awarded Lili Cruchelow, principal of TLC Medical, the 2012 SafeBaby Dealer of the Year. TLC Medical sold three SafeBaby Systems to Essentia Health in Duluth, MN; Essentia Health in Fargo, ND; and St. Francis Medical Center in Cape Girardeau, MO. The SafeBaby System electronically tracks human breast milk providing the most comprehensive solution for safe and secure enteral feeding in the critical care environment. TLC employs knowledgeable sales professionals, three of which have attended NeoMed New Rep training in the last year. Headquartered in Davenport, Iowa, TLC represents products that offer a clinical advantage: improving outcomes, care, efficiency, and cost management.
Woodstock, GA – November 13, 2012 – NeoMed, Inc. has been awarded the GOAL Achievement Award by representatives of Georgia GOAL Scholarship Program, and Pinecrest Academy in Cumming, GA.
The GOAL Achievement Award recognizes a corporation that has made a significant financial investment in the lives of Georgia children through a contribution to the Georgia GOAL Scholarship Program.
NeoMed designated its contribution be used to provide scholarships for students from low and middle income families to attend Pinecrest Academy. The GOAL Achievement Award acknowledges NeoMed for providing Georgia parents with more options for the education of their children.
Regina Gore, Annual Giving Coordinator said, “We are so appreciative of the generosity of NeoMed. Their financial investment in Pinecrest Academy through GOAL has impacted the lives of many students desiring a private school education.”
Mrs. Gore explained that the mission of Pinecrest Academy is to: form Christian leaders who will transform society.
Lisa Kelly, Georgia GOAL Scholarship Program president said, “It is important for students to have the option of a private school that fits their needs if they can’t achieve their full potential in their local public school. I am thankful to NeoMed for creating an opportunity to improve educational outcomes and to allow families to put their children on paths to success.”
Kelly explained that Georgia GOAL Scholarship Program, is the state’s leading student scholarship organization. Providing children throughout the Peach State with Greater Opportunities for Access to Learning (“GOAL”), the program has awarded more than 6,000 scholarships totaling more than $22.3 million since 2008.
NeoMed, Inc., formed in 2007, is a leading manufacturer of neonatal feeding devices dedicated to enhancing patient safety. NeoMed is dedicated to supporting the clinician with a wide variety of clinical material that can be used to enhance patient care.
Woodstock, GA – October, 2012 – NeoMed, Inc. announced today that it has received 510(k) clearance by the FDA to extend the NeoMed Sterile Oral Enteral Syringe family to include sizes ranging from 0.5 mL to 100 mL.
This clearance allows NeoMed to produce the FIRST Sterile 100 mL Oral Enteral Syringe on the market. While delivering gravity feeds, the Sterile 100 mL Oral Enteral Syringe has a unique vent zone and plunger fenestration for quick placement on a pole. The Sterile 100 mL Oral Enteral Syringe is currently validated in several leading syringe infusion pumps and is ideal for pump feeds requiring volumes over 60 mL.
NeoMed President Tony Lair commented, “NeoMed is committed to developing and manufacturing the highest quality devices for proper enteral delivery, and our sterile devices from syringes to feeding tubes help ensure that valuable human breast milk has an aseptic pathway to the belly of premature babies.” Proper handling and management of human breast milk in patient care settings is an important factor in reducing dangerous gut disease and other hospital born infections. The Sterile 100 mL Oral Enteral Syringe, like all enteral delivery devices in NeoMed’s Enteral Safety System, is designed to be incompatible with Luer and IV devices to reduce the risk of misconnection errors.
Woodstock, GA – May, 2012 – NeoMed, Inc. currently is featured in the May 2012 issue of Health Purchasing News. Susan Cantrell’s article Patient Nutrition Hinges on Process Safety, Efficiency explores the unique challenges involved with enteral feeding, including misconnection errors. The article highlighted the Enteral Safety System, which prevents dangerous misconnection errors with IV or Luer locking devices, the 100 mL Oral/Enteral Syringe, and the NeoBottle. To read more about the safety features and cost effective products mentioned in the article, click here.
Cleveland, OH – April 2012 – On April 16th, 2012, Paragon Data Systems launched their new SpaceLabs™ Feed Validation system. This groundbreaking solution allows NICU staff to validate expressed breast milk, donor milk, and formula feeds at the bedside through access within SpaceLab’s bedside monitors and in close proximity to the baby. For additional information, please visit www.safebabybmt.com.
Woodstock, GA – March, 2012 – NeoMed, Inc. is proud to announce a new contract agreement that will supply Children’s Hospital Association with NeoMed’s full line of neonatal products. CHA is an alliance of non-competing children’s hospitals that represent more than 20,000 physicians, 100,000 employees, $14 billion in revenue, and $1.8 billion in overall medical, surgical, and pharmaceutical products. CHA Owner Hospitals and Members will have access to NeoMed’s Enteral Safety System, including enteral syringes, feeding tubes, and extension sets, as well as breast milk tracking technology, designed to prevent dangerous misconnection errors and misfeeds. NeoMed, Inc. is committed to producing the highest quality medical devices and is honored to support CHA’s mission of “advancing the safety and quality of care to children.” The term of agreement for this contract continues through September 30, 2013. For more information, click here.
Woodstock, GA – January, 2012 – NeoMed, Inc. announces the sale and installation of the fifth stand-alone SafeBaby system in the Georgia region. Over the past 2 years, five independent Level III Neonatal ICUs surrounding Atlanta, Georgia have selected to operate the SafeBaby Breast Milk Tracking (BMT) system from NeoMed. SafeBaby utilizes advanced software and barcode technology to provide a simple and seamless breast milk tracking system that insures preemie babies receive validated breast milk and enteral nutrition. Simple implementation of the SafeBaby system results in higher nurse productivity and lower risks associated with mis-identification of patients, errors in compounding of nutrition, and the feeding of outdated or spoiled nutrition. For additional information, please visit www.neomedinc.com or www.safebabybmt.com.
Woodstock, GA – October, 2011 – NeoMed is pleased to announce new distribution agreements in sections of Europe and Singapore for its Enteral Safety System. “These new distributor agreements continue the global marketing initiative designed to strengthen our worldwide presence and demonstrate our ongoing commitment to patient safety” said Tony Lair… “We welcome the opportunity to improve neonatal and pediatric care and patient outcomes internationally. Hospitals will now be able to purchase products from NeoMed’s extensive neonatal line, including oral/enteral syringes, NeoBottle™ dispensers, enteral feeding tubes and extension sets.” NeoMed’s market leading enteral safety system is a comprehensive system including feeding tubes, enteral sets and enteral syringes that uniquely protects the patient from the risk of enteral misconnections.
